A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence

Addictive Behaviors

Volumn 28, Issue 3, 2003, Pages 437-448

  Kampman, Kyle ^a,b,e   Majewska, Maria Dorota ^c   Tourian, Karen ^d   Dackis, Charles ^a   Cornish, James ^a,b   Poole, Sabrina ^a,b   O'Brien, Charles ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d Department of Psychiatry   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Clinical trial; Cocaine; Ginkgo biloba; Piracetam

Indexed keywords

BENZOYLECGONINE; GINKGO BILOBA EXTRACT; PIRACETAM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERMENORRHEA; MALE; MYALGIA; NAUSEA; OUTCOMES RESEARCH; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RESPIRATORY TRACT INFECTION; SCORING SYSTEM; TREATMENT FAILURE; URINALYSIS;

EID: 0344838540     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4603(02)00226-5     Document Type: Article

References (42)

1. Ardila A., Rosselli M., Strumwasser S. Neuropsychological deficits in chronic cocaine abusers. International Journal of Neuroscience. 57:1991;73-79.
2. Beck A.T., Beamsdorfer A. Assessment of depression: the depression inventory. Modern Problems of Pharmacopsychiatry. 7:1974;151-169.
3. Beck A.T., Epstein N., Brown G., Steer R.A. An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology. 56(6):1988;893-897.
4. Calapai G., Crupi A., Firenzuoli F., Marciano M.C., Squadrito F., Inferrera G., Parisi A., Rizzo A., Crisafulli C., Fiore A., Caputi A.P. Neuroprotective effects of ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis. Life Sciences. 67(22):2000;2673-2683.
5. DeMay F., Bande J. The effect of piracetam on volunteers in a low pressure tank. Journal of International Medical Research. 8:1980;90-94.
6. Dixon W.J. BMDP statistical software manual. 1992;University of California Press, Berkeley.
7. Ernst T., Chang L., Oropilla G., Gustavson A., Speck O. Cerebral perfusion abnormalities in abstinent cocaine abusers: a perfusion MRI and SPECT study. Psychiatry Research. 99(2):2000;63-74.
8. Ezzat D.H., Ibraheem M.M., Makhawy B. The effect of piracetam on ECT induced memory disturbance. British Journal of Psychiatry. 147:1985;720-721.
9. Feldman J., Rouse B. Summary findings from the National Household Survey on Drug Abuse. 2000;Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Rockville, MD.
10. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I disorders - Subject Edition (SCID-I/P, Version 2.0). 1996;Biometrics Research Department, New York State Psychiatric Institute, New York.
11. Folstein M., Folstein S. Mini-mental state: a practical method for grading the cognitive state of patients for clinicians. Journal of Psychiatric Research. 12:1975;189-198.
12. Guy W. Assessment manual for psychopharmacology: publication ADM 76-338. 1976;US Department of Health Education and Welfare, Washington, DC.
13. Herning R.I., Glover B.J., Koeppl B., Weddington W., Jaffe J.H. Cognitive deficits in abstaining cocaine abusers. NIDA Research Monograph. 101:1990;167-178.
14. Holman B.L., Carvalho P.A., Mendelson J., Teoh S.K., Nardin R., Hallgring E., Hebben N., Johnson K.A. Brain perfusion is abnormal in cocaine-dependent polydrug users: a study using technetium-99-m-HMPAO and ASPECT. Journal of Nuclear Medicine. 32(6):1991;1206-1210.
15. Kanowski S., Herrmann W.M., Stephan K., Wierich R., Horr R. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the alzheimer type or multi-infarct dementia. Pharmacopsychiatry. 29:1996;47-56.
16. Kennedy D.O., Scholey A.B., Wesnes K.A. The dose-dependent cognitive effects of acute administration of ginkgo biloba to healthy volunteers. Psychopharmacology (Berlin). 151(4):2000;416-423.
17. Kleijnen J., Knipschild P. Ginkgo biloba. Lancet. 340:1992;1136-1139.
18. Kosten T.R., Cheeves C., Palumbo J., Seibyl J.P., Price L.H., Woods S.W. Regional cerebral blood flow during acute and chronic abstinence from combined cocaine and alcohol abuse. Drug and Alcohol Dependence. 50(3):1998;187-195.
19. LeBars P.L., Katz M.M., Berman N., Itil T.M., Freedman A.M., Schatzberg A.F. A placebo-controlled, double-blind randomized trial of an extract of ginkgo biloba for dementia. Journal of the American Medical Association. 278(16):1997;1327-1332.
20. Manschreck T.C., Schneyer M.L., Weissten C., Laughery J., Rosenthal J., Celada T., Berner J. Freebase cocaine and memory. Comprehensive Psychiatry. 31(4):1990;369-375.
21. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment. 9(3):1992;199-213.
22. Mindus P., Cronholm B., Levander S.E., Schalling D. Piracetam-induced improvement of mental performance. A controlled study on normally aging individuals. Acta Psychiatrica Scandinavica. 54(2):1976;150-160.
23. O'Malley S., Adamse M., Heaton R.K., Gawin F.H. Neuropsychological impairment in chronic cocaine abusers. American Journal of Drug and Alcohol Abuse. 18(2):1992;131-144.
24. Otani M., Chaterjee S.S., Gabard B., Kreutzberg G.W. Effect of an extract of Ginkgo biloba on triethyltin-induced cerebral edema. Acta Neuropathologica (Berlin). 69(1-2):1986;54-65.
25. Pascual-Leone A., Dhuna A., Anderson D.C. Cerebral atrophy in habitual cocaine abusers: a planimetric CT study. Neurology. 41(1):1991;34-38.
26. Princemail J., Dupuis M., Nasr C., Hans P., Haag-Berrurier M., Anton R., Deby C. Superoxide anion scavenging effect and superoxide dismutase activity of Ginkgo biloba extract. Experientia. 45(8):1989;708-712.
27. Rai G.S., Shovlin C., Wesnes K.A. A double-blind, placebo controlled study of ginkgo biloba extract (tanakan) in elderly outpatients with mild to moderate memory impairment. Current Medical Research Opinion. 12(6):1991;350-355.
28. Rosenblatt M., Mindel J. Spontaneous hyphema associated with ingestion of ginkgo biloba extract. New England Journal of Medicine. 336(15):1997;1108.
29. Rowin J., Lewis S.L. Spontaneous bilateral subdural hematomas associated with chronic ginkgo biloba ingestion. Neurology. 46:1996;1775-1776.
30. Sano M., Stern Y., Marder K., Mayeux B. A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease. Movement Disorders. 1985.
31. SAS/STAT software: changes and enhancements. 1996;SAS Institute, Cary, NC.
32. Schmidt U., Brendelmuhl D., Engels K., Schenk N., Luderman E. Piracetam in elderly motorists. Pharmacopsychiatry. 24(4):1991;121-126.
33. Smelson D.A., Roy A., Santana S., Engelhart C. Neuropsychological deficits in withdrawn cocaine-dependent males. American Journal of Drug and Alcohol Abuse. 25(2):1999;377-381.
34. Smith A. A symbol digit modalities test (22). 1982;Western Psychological Services, Los Angeles.
35. Strickland T.L., Mena I., Villanueva-Meyer J., Miller B.L., Cummings J., Mehringer C.M., Satz P., Myers H. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. Journal of Neuropsychiatry and Clinical Neuroscience. 5(4):1993;419-427.
36. Sutter M.C., Wang Y.X. Recent cardiovascular drugs from Chinese medicinal plants. Cardiovascular Research. 27(11):1993;1891-1901.
37. Trites, R. L., Suh, M., Offord, D., Nieman, G., & Preston, D. (1974). Neuropsychological and psychosocial antecedents and chronic effects of prolonged use of solvents and methamphetamine. Paper presented at the International Psychiatric Research Society, Ottawa, Canada.
38. Tumeh S.S., Nagel J.S., English R.J., Moore M., Holman B.L. Cerebral abnormalities in cocaine abusers: demonstration by SPECT perfusion brain scintigraphy. Work in progress. Radiology. 176(3):1990;821-824.
39. van Dongen M.C., van Rossum E., Kessels A.G., Sielhorst H.J., Knipschild P.G. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairments: new results of a randomized clinical trial. Journal of the American Geriatric Society. 48(10):2000;1183-1194.
40. Vernon M.W., Sorkin E.M. Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders. Drugs and Aging. 1(1):1991;17-35.
41. Volkow N.D., Hitzeman R., Wang G.J., Fowler J.S., Wolf A.P., Dewey S.L., Handlesman L. Long-term frontal brain metabolic changes in cocaine abusers. Synapse. 11(3):1992;184-190.
42. Wesnes K.A., Ward T., McGinty A., Petrini O. The memory enhancing effects of a ginkgo/panax ginseng combination in healthy middle aged volunteers. Psychopharmacology (Berlin). 152(4):2000;353-361.